Original Research Online Publishing Date: | ||||||||||||||||||||||||||||||
Safety profile of second-line agents as add-on to oral monotherapy or dual therapy in uncomplicated type 2 diabetes in South Indian population Rupam Gill, Shalini Adiga, Muralidhar Varma.
|
How to Cite this Article |
Pubmed Style Rupam Gill, Shalini Adiga, Muralidhar Varma. Safety profile of second-line agents as add-on to oral monotherapy or dual therapy in uncomplicated type 2 diabetes in South Indian population. Natl J Physiol Pharm Pharmacol. 2018; 8(8): 1097-1106. doi:10.5455/njppp.2018.8.0208302042018 Web Style Rupam Gill, Shalini Adiga, Muralidhar Varma. Safety profile of second-line agents as add-on to oral monotherapy or dual therapy in uncomplicated type 2 diabetes in South Indian population. https://www.njppp.com/?mno=292323 [Access: March 14, 2024]. doi:10.5455/njppp.2018.8.0208302042018 AMA (American Medical Association) Style Rupam Gill, Shalini Adiga, Muralidhar Varma. Safety profile of second-line agents as add-on to oral monotherapy or dual therapy in uncomplicated type 2 diabetes in South Indian population. Natl J Physiol Pharm Pharmacol. 2018; 8(8): 1097-1106. doi:10.5455/njppp.2018.8.0208302042018 Vancouver/ICMJE Style Rupam Gill, Shalini Adiga, Muralidhar Varma. Safety profile of second-line agents as add-on to oral monotherapy or dual therapy in uncomplicated type 2 diabetes in South Indian population. Natl J Physiol Pharm Pharmacol. (2018), [cited March 14, 2024]; 8(8): 1097-1106. doi:10.5455/njppp.2018.8.0208302042018 Harvard Style Rupam Gill, Shalini Adiga, Muralidhar Varma (2018) Safety profile of second-line agents as add-on to oral monotherapy or dual therapy in uncomplicated type 2 diabetes in South Indian population. Natl J Physiol Pharm Pharmacol, 8 (8), 1097-1106. doi:10.5455/njppp.2018.8.0208302042018 Turabian Style Rupam Gill, Shalini Adiga, Muralidhar Varma. 2018. Safety profile of second-line agents as add-on to oral monotherapy or dual therapy in uncomplicated type 2 diabetes in South Indian population. National Journal of Physiology, Pharmacy and Pharmacology, 8 (8), 1097-1106. doi:10.5455/njppp.2018.8.0208302042018 Chicago Style Rupam Gill, Shalini Adiga, Muralidhar Varma. "Safety profile of second-line agents as add-on to oral monotherapy or dual therapy in uncomplicated type 2 diabetes in South Indian population." National Journal of Physiology, Pharmacy and Pharmacology 8 (2018), 1097-1106. doi:10.5455/njppp.2018.8.0208302042018 MLA (The Modern Language Association) Style Rupam Gill, Shalini Adiga, Muralidhar Varma. "Safety profile of second-line agents as add-on to oral monotherapy or dual therapy in uncomplicated type 2 diabetes in South Indian population." National Journal of Physiology, Pharmacy and Pharmacology 8.8 (2018), 1097-1106. Print. doi:10.5455/njppp.2018.8.0208302042018 APA (American Psychological Association) Style Rupam Gill, Shalini Adiga, Muralidhar Varma (2018) Safety profile of second-line agents as add-on to oral monotherapy or dual therapy in uncomplicated type 2 diabetes in South Indian population. National Journal of Physiology, Pharmacy and Pharmacology, 8 (8), 1097-1106. doi:10.5455/njppp.2018.8.0208302042018 |